FDA Memo Reveals Link Between Child Deaths and COVID-19 Vaccination

An internal memo from the Food and Drug Administration (FDA) has disclosed that agency scientists have identified at least ten child deaths they believe are linked to COVID-19 vaccinations. This revelation, detailed by Dr. Vinay Prasad, director of the FDA’s Center for Biologics Evaluation and Research (CBER), represents a significant acknowledgment within the agency regarding the potential risks associated with these vaccines.

The memo, which was obtained by The Epoch Times, outlines findings from a review conducted by the FDA’s Office of Biostatistics and Pharmacovigilance. The review examined 96 death reports submitted to the Vaccine Adverse Event Reporting System (VAERS) between 2021 and 2024. Of these reports, the FDA scientists concluded that at least ten deaths met the criteria for a likely, probable, or possible causal link to the vaccines.

Details of the Findings

The memo indicates that the review process involved a thorough evaluation of the circumstances surrounding each reported death. The scientists focused on the medical histories of the children, the timing of vaccinations, and other relevant factors that could establish a connection to the vaccine. This internal assessment marks a notable shift in the FDA’s approach to vaccine safety, especially regarding its communication about potential adverse effects.

According to the memo, the identification of these cases raises important questions about the ongoing monitoring and evaluation of vaccine safety protocols. The findings have sparked discussions among health professionals and public health advocates about the need for increased transparency in reporting adverse events related to vaccines.

Public and Professional Reactions

The release of this memo has prompted varied responses from health experts and the public. Some health professionals emphasize the importance of rigorous safety monitoring and the need to inform parents about potential risks. Others argue that the benefits of COVID-19 vaccination in preventing severe illness and hospitalization in children outweigh the risks associated with rare adverse events.

As the FDA continues to review vaccine safety, the agency faces the challenge of balancing public health interests with the necessity for clear communication. The acknowledgment of a possible link between COVID-19 vaccinations and child deaths may lead to further scrutiny and debate around childhood vaccination programs.

The FDA has not released specific details regarding the cases of the identified fatalities, nor has it stated whether any changes to vaccination guidelines will be considered. The agency maintains that the overall benefits of COVID-19 vaccines in controlling the pandemic remain significant.

As the situation develops, it is crucial for parents, healthcare providers, and policy-makers to stay informed through reliable sources. The FDA is expected to continue its investigation into the vaccine’s safety profile, including any further assessments of the data collected through VAERS.